CENTENE CORPORATION 2026 GUIDANCE $7.5 $0 ($ IN BILLIONS) Medicaid $88 $34.5 $45 $4.5 Medicaid Com mercial Medicare Other Marketplace Medicare Advantage $174.6 $172.0 2026 Estimated Segment Premium & Service Revenue1 2026 Guidance Mid-point 2025 Actual Medicare PDP ($8.1) ($2.0) FEBRUARY 2026 Forward-Looking Statements All statements, other than statements of current or historical fact, contained in this presentation are forward-looking statements. Without limiting the foregoing, forward-looking statements ...

Centene (CNC) came out with a quarterly loss of $1.19 per share versus the Zacks Consensus Estimate of a loss of $1.25. This compares to earnings of $0.8 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +4.76%. A quarter ago, it was expected that this healthcare company would post a loss of $0.21 per share when it actually produced earnings of $0.5, delivering a surprise of +338.1%.Over the last four quarters, the company has s ...

Core Insights - Centene reported a fourth-quarter loss despite an increase in revenue, indicating ongoing challenges in achieving profitability and stabilizing its Medicaid business [1] Financial Performance - The company experienced a loss in the fourth quarter, which contrasts with its higher revenue figures [1] Business Operations - Centene is actively working to restore profitability and stabilize its Medicaid operations, highlighting the focus on improving its core business segment [1]

Core Insights - Centene Corporation reported a GAAP diluted loss per share of $(13.53) for the full year 2025, primarily due to a goodwill impairment of $6.7 billion, while the adjusted diluted earnings per share (EPS) was $2.08 [1][19] - For 2026, the company expects adjusted diluted EPS to exceed $3.00, indicating a positive outlook for profitability and margin improvement [1] Financial Performance - Total revenues for Q4 2025 were $49.725 billion, a 23% increase from $36.296 billion in Q4 2024; full-year revenues reached $194.777 billion, up 20% from $145.505 billion in 2024 [1][12] - Premium and service revenues for Q4 2025 were $44.727 billion, compared to $36.296 billion in Q4 2024, driven by growth in the PDP and Marketplace businesses [1][12] - The health benefits ratio (HBR) for Q4 2025 was 94.3%, up from 89.6% in Q4 2024, while the full-year HBR was 91.9%, an increase from 88.3% in 2024 [1][12] Membership Trends - Total at-risk membership as of December 31, 2025, was 27.634 million, a slight decrease from 28.601 million in 2024; traditional Medicaid membership decreased to 10.933 million from 11.408 million [6] - Marketplace membership increased significantly to 5.541 million from 4.382 million in 2024, indicating strong growth in this segment [6] Operational Efficiency - The SG&A expense ratio for Q4 2025 was 7.5%, down from 8.9% in Q4 2024; the full-year SG&A expense ratio was also 7.4%, compared to 8.5% in 2024, reflecting improved expense management [1][12] - Cash flow from operations for the full year 2025 was $5.088 billion, driven by improved timing of pharmacy rebates and higher medical claims liabilities [1][19] Strategic Developments - In December 2025, Centene signed an agreement to divest the remaining Magellan Health businesses, resulting in non-cash impairment charges of $513 million [2][12] - The company has engaged in community support initiatives, including contributions to food banks and partnerships aimed at addressing housing insecurity [5][9]

Centene Corporation (NYSE:CNC) will release earnings for its first quarter before the opening bell on Friday, Feb. 6.Analysts expect the Saint Louis, Missouri-based company to report quarterly loss of $1.22 per share. That's up from 80 cents per share in the year-ago period. The consensus estimate for Centene's quarterly revenue is $48.35 billion (it reported $40.8 billion last year), according to Benzinga Pro.On Oct. 29, Centene reported better-than-expected third-quarter financial results.Shares of Centen ...

Core Viewpoint - Centene Corporation is expected to report a quarterly loss of $1.22 per share for the first quarter, an increase from $0.80 per share in the same period last year [1] Financial Performance - The consensus estimate for Centene's quarterly revenue is $48.35 billion, compared to $40.8 billion reported last year [1] - Centene reported better-than-expected third-quarter financial results on October 29 [1] Stock Performance - Shares of Centene fell 2.5% to close at $39.92 on Thursday [2]

Exhibit 99.1 N E W S R E L E A S E Contact: Investor Relations Inquiries Media Inquiries Jennifer Gilligan Sara Garland Senior Vice President, Finance & Investor Relations Chief Communications Officer (212) 549-1306 (314) 445-0790 FOR IMMEDIATE RELEASE CENTENE CORPORATION REPORTS 2025 RESULTS AND ANNOUNCES 2026 GUIDANCE -- 2025 Full Year GAAP Diluted Loss Per Share of $(13.53); Adjusted Diluted Earnings Per Share of $2.08 -- -- 2026 Adjusted Diluted Earnings Per Share Guidance of Greater than $3.00 -- ST. L ...

Core Insights - Centene Corporation (CNC) is expected to report a fourth-quarter 2025 loss of $1.25 per share on revenues of $48.24 billion, indicating a significant year-over-year earnings decline of 256.3% despite revenue growth of 18.2% [1][2] Financial Performance - The Zacks Consensus Estimate for Centene's total revenues in 2025 is $192.12 billion, reflecting a year-over-year increase of 17.8%, while the EPS estimate for 2025 is $2.01, indicating a 72% decrease year-over-year [3] - Centene has beaten earnings estimates in three of the last four quarters, with an average surprise of 75.2% [3] Earnings Predictions - The current model does not predict an earnings beat for Centene, as it has an Earnings ESP of 0.00% and a Zacks Rank of 4 (Sell) [4] Membership and Premiums - Centene's premiums are projected to rise by 22.5% year-over-year, driven by gains in commercial membership, although total membership is expected to decline by 2.4% [7][9] - The Zacks Consensus Estimate indicates a 29.7% year-over-year increase in total commercial memberships and a 15.6% growth in Medicare PDP memberships [8] Cost and Margin Pressures - The total health benefits ratio is estimated to be 93.7%, up from 89.6% in the previous year, indicating increased medical costs that are expected to pressure earnings [10] Industry Comparisons - UnitedHealth Group reported a fourth-quarter adjusted EPS of $2.11, beating estimates but showing a 69% year-over-year decline due to elevated medical costs [11] - Elevance Health reported an adjusted EPS of $3.33, surpassing estimates and showing a 3.1% year-over-year increase, although it faced challenges from declining overall medical membership [12]

Core Viewpoint - Centene Corporation, a healthcare enterprise based in Missouri, has faced significant stock performance challenges, particularly a 33% decline over the past year, while showing slight improvement in 2026 with a 5.3% year-to-date growth [2][4]. Company Overview - Centene Corporation was founded in 1984 and operates as a healthcare enterprise providing services to under-insured and uninsured families and commercial organizations in the U.S. The company has a market capitalization of $21.3 billion and operates through various segments including Medicaid, Medicare, Commercial, and Other [1]. Stock Performance - Over the past year, Centene's stock has underperformed compared to the broader market, with a 33% decline, while the S&P 500 Index has returned 14.3% [2]. In 2026, the stock has slightly outperformed the S&P 500, which has risen by 1.4% [2]. Market Reaction - A significant drop of 10.7% in Centene's stock occurred on January 27 following the Centers for Medicare & Medicaid Services' announcement of a lower-than-expected payment rate increase of only 0.09% for 2027 Medicare Advantage plans, which raised concerns about the viability of government-sponsored health plan providers [4]. Earnings Outlook - For the fiscal year ending December 2025, analysts expect Centene to report a 72% year-over-year decline in adjusted EPS to $2.01. The company has a mixed earnings surprise history, surpassing estimates in three of the past four quarters [5]. Analyst Ratings - Centene currently holds a consensus "Hold" rating, with 19 analysts covering the stock, including four "Strong Buys," 13 "Holds," one "Moderate Sell," and one "Strong Sell." The sentiment has improved recently, with an increase in "Strong Buy" ratings [6]. Price Target Adjustments - Analysts have recently adopted a more positive outlook for Centene, with Mizuho raising its price target to $47 from $40 while maintaining a "Neutral" rating, and Wells Fargo increasing its target to $43 from $35 while keeping an "Equal Weight" stance [8].

Group 1: Company Overview - Centene Corporation (NYSE:CNC) is a healthcare enterprise that provides programs and services to under-insured and uninsured families and commercial organizations in the US [4] Group 2: Analyst Ratings and Price Targets - Mizuho increased its price target for Centene from $40 to $47 while maintaining a Neutral rating, indicating a cautious outlook due to decelerating healthcare utilization growth [1] - Wells Fargo raised its price target for Centene to $43 from $35 with an Equal Weight rating, expressing concerns about high uncertainty in Medicaid and Exchanges and a challenging environment for hospitals in 2026 [2] - Bernstein analyst Lance Wilkes raised the price target for Centene to $59 from $45 with an Outperform rating, anticipating a sector-wide turnaround in government managed care starting in 2026 [3] Group 3: Market Trends and Insights - Recent physician surveys suggest that healthcare utilization growth is decelerating, which may indicate that the utilization trend is currently peaking [1] - The managed care sector is expected to face challenges as post-COVID tailwinds diminish and legislative risks increase [2] - Current levels across all managed care organization sectors are viewed as attractive entry points for investors despite anticipated volatility [3]